Efavirenz
In the US, Efavirenz (efavirenz systemic) is a member of the drug class NNRTIs and is used to treat HIV Infection, Nonoccupational Exposure and Occupational Exposure.
US matches:
- Efavirenz
- Efavirenz/emtricitabine/tenofovir
- Efavirenz, emtricitabine, and tenofovir
- Efavirenz, emtricitabine, y tenofovir
- Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate
UK matches:
Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
J05AG03
CAS registry number (Chemical Abstracts Service)
0154598-52-4
Chemical Formula
C14-H9-Cl-F3-N-O2
Molecular Weight
315
Therapeutic Categories
Antiviral agent
Non-nucleoside reverse transcriptase inhibitor (NNRTI)
Treatment of HIV infection
Chemical Name
(S)-6-chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one (WHO, Ph. Int.)
Foreign Names
- Efavirenzum (Latin)
- Efavirenz (German)
- Éfavirenz (French)
- Efavirenz (Spanish)
Generic Names
- Efavirenz (OS: BAN)
- Éfavirenz (OS: DCF)
- DMP 266 (IS: DuPont Merck)
- L 743726 (IS: DuPont Merck)
- Efavirenz (PH: Ph. Int. 4)
- Efavirenzum (PH: Ph. Int. 4)
Brand Names
- Adco-Efavirenz
Adcock Ingram Pharmaceuticals, South Africa - Adiva
Square, Bangladesh - Aspen Efavirenz
Aspen Pharmacare, South Africa - Atripla (Efavirenz and Emtricitabine, + Tenofovir)
Bristol-Myers Squibb, Iceland; Bristol-Myers Squibb, Italy; Bristol-Myers Squibb, Slovenia; Bristol-Myers Squibb and Gilead, Austria; Gilead, Australia; Gilead, Belgium; Gilead, Switzerland; Gilead, Denmark; Gilead, Spain; Gilead, Finland; Gilead, United Kingdom; Gilead, Norway; Gilead, Sweden; Gilead, United States; HAEMATO pharm, Austria; Bristol-Myers Squibb, Greece - ATRIPLA (Efavirenz and Emtricitabine, + Tenofovir)
Bristol-Myers Squibb, Germany; Gilead, Germany - Avifanz
Beximco, Bangladesh - Aviranz
Ranbaxy Laboratories, Ethiopia - Cipla-Efavirenz
Cipla Medpro, South Africa - Efatec
Zifam India, Myanmar - Efavir
Cipla, Georgia; Cipla, India; Pharmaceutical, Venezuela - Efavirenz Stada
Stada-VN JV, Vietnam - Efcure
Emcure, Georgia - Efferven
Ranbaxy, India - Estival
Hetero, Georgia - Evirenz
Alkem, India - Filginase
Filaxis, Argentina - Sonke-Efavirenz
Sonke, South Africa - Stocrin
Du Pont, Luxembourg; Merck, South Korea; Merck Sharp & Dohme, Argentina; Merck Sharp & Dohme, Austria; Merck Sharp & Dohme, Australia; Merck Sharp & Dohme, Aruba; Merck Sharp & Dohme, Barbados; Merck Sharp & Dohme, Belgium; Merck Sharp & Dohme, Bahamas; Merck Sharp & Dohme, Chile; Merck Sharp & Dohme, China; Merck Sharp & Dohme, Costa Rica; Merck Sharp & Dohme, Czech Republic; Merck Sharp & Dohme, Ethiopia; Merck Sharp & Dohme, Finland; Merck Sharp & Dohme, Greece; Merck Sharp & Dohme, Guatemala; Merck Sharp & Dohme, Hong Kong; Merck Sharp & Dohme, Honduras; Merck Sharp & Dohme, Croatia (Hrvatska); Merck Sharp & Dohme, Hungary; Merck Sharp & Dohme, Israel; Merck Sharp & Dohme, Iceland; Merck Sharp & Dohme, Jamaica; Merck Sharp & Dohme, Cayman Islands; Merck Sharp & Dohme, Lithuania; Merck Sharp & Dohme, Latvia; Merck Sharp & Dohme, Mexico; Merck Sharp & Dohme, Malaysia; Merck Sharp & Dohme, Nicaragua; Merck Sharp & Dohme, Netherlands; Merck Sharp & Dohme, Norway; Merck Sharp & Dohme, New Zealand; Merck Sharp & Dohme, Panama; Merck Sharp & Dohme, Poland; Merck Sharp & Dohme, Portugal; Merck Sharp & Dohme, Romania; Merck Sharp & Dohme, Serbia; Merck Sharp & Dohme, Singapore; Merck Sharp & Dohme, Slovenia; Merck Sharp & Dohme, Slovakia; Merck Sharp & Dohme, El Salvador; Merck Sharp & Dohme, Thailand; Merck Sharp & Dohme, Tunisia; Merck Sharp & Dohme, Turkey; Merck Sharp & Dohme, Trinidad & Tobago; Merck Sharp & Dohme, Venezuela; MSD, Switzerland; MSD, Denmark; MSD, Sweden; MSD, South Africa - Sulfinav
LKM, Argentina - Sustiva
Bristol Myers Squibb, Spain; Bristol Myers Squibb, Latvia; Bristol-Myers Squibb, Canada; Bristol-Myers Squibb, France; Bristol-Myers Squibb, United Kingdom; Bristol-Myers Squibb, Ireland; Bristol-Myers Squibb, Italy; Bristol-Myers Squibb, Lithuania; Bristol-Myers Squibb, United States; Du Pont, Luxembourg - SUSTIVA
Bristol-Myers Squibb, Germany - Virorrever
Richmond, Argentina - Virzen
Biogen, Colombia
International Drug Name Search
Glossary
| Term | Definition |
|---|---|
| BAN | British Approved Name |
| DCF | Dénomination Commune Française |
| IS | Inofficial Synonym |
| OS | Official Synonym |
| PH | Pharmacopoeia Name |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
Click for further information on drug naming conventions and International Nonproprietary Names.
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.


